<div class="docx-content">
<h1 class="text-2xl font-bold mt-8 mb-4"><strong>Borrelia Infections</strong></h1><p><em>Borrelia</em> are spirochaetes, causing two main human disease groups:</p><ol><li><strong>Lyme disease (Lyme borreliosis)</strong></li><li><strong>Relapsing fevers</strong> (louse-borne, tick-borne, <em>B. miyamotoi</em>)</li></ol><h2 class="text-xl font-semibold mt-6 mb-3"><strong>I. Lyme Disease (Lyme Borreliosis)</strong></h2><h3 class="text-lg font-semibold mt-6 mb-3"><strong>Epidemiology</strong></h3><ul><li><strong>Most common tick-borne disease in Northern Hemisphere.</strong></li><li><strong>Causative organisms</strong>:<ul><li>US → <em>Borrelia burgdorferi sensu stricto</em>.</li><li>Europe/Asia → <em>B. garinii</em>, <em>B. afzelii</em>, <em>B. burgdorferi s.s.</em> (i.e the entirity, the sensu lato complex).</li></ul></li><li><strong>Vector: Ixodes</strong><ul><li><em>Ixodes scapularis</em> - US NE/Midwest</li><li><em>I. pacificus</em> - Pacific US</li><li><em>I. ricinus</em> - Europe</li><li><em>I. persulcatus</em> - Asia.</li></ul></li><li><strong>Reservoirs</strong>: Rodents and birds.</li><li><strong>UK incidence</strong>: ~2–3,000 confirmed cases/year; highest in South England and Scottish Highlands.</li></ul><h3 class="text-lg font-semibold mt-6 mb-3"><strong>Clinical Features</strong></h3><ul><li><strong>Stage 1 (Early Localised)</strong>:<ul><li><em>Erythema migrans</em> (diagnostic expanding rash, &gt;5 cm).</li><li>Local lymphadenopathy, flu-like illness.</li><li>Rare: <em>Borrelial lymphocytoma</em> (Europe).</li></ul></li><li><strong>Stage 2 (Early Disseminated)</strong>:<ul><li>Multiple EM lesions.</li><li>Neuro: lymphocytic meningitis, cranial nerve palsy (esp. facial), radiculitis.</li><li>Cardiac: AV block, myocarditis.</li></ul></li><li><strong>Stage 3 (Late/Persistent)</strong>:<ul><li>Arthritis (mono/oligo, esp. knee; common in US).[<em>B. burgdorferi]</em></li><li>Acrodermatitis chronica atrophicans (Europe). [<em>B. afzelii]</em></li><li>Chronic neuroborreliosis (polyneuropathy, encephalopathy).  [<em>B. garinii]</em></li></ul></li></ul><h3 class="text-lg font-semibold mt-6 mb-3"><strong>Diagnosis</strong></h3><ul><li><strong>Clinical</strong>: Erythema migrans is diagnostic</li><li><strong>Serology</strong>: 2-tier (ELISA → Western blot). Negative early; cross-reactions possible.</li><li><strong>PCR</strong>: Useful for CSF, synovial fluid, skin biopsies (variable sensitivity).</li><li><strong>Culture</strong>: Rare, BSK medium.</li></ul><h3 class="text-lg font-semibold mt-6 mb-3"><strong>Treatment</strong></h3><table><tr><td><p><strong>Clinical Presentation</strong></p></td><td><p><strong>Adults &amp; ≥12y</strong></p></td><td><p><strong>Children 9–12y</strong></p></td><td><p><strong>Children &lt;9y</strong></p></td><td><p><strong>Pregnancy</strong></p></td></tr><tr><td><p><strong>Erythema migrans, </strong></p><p><strong>non-focal systemic symptoms, cranial nerve</strong></p><p><strong>peripheral neuroborreliosis</strong></p></td><td><ul><li><strong>Doxycycline 100 mg bd × 21d</strong></li><li>Amoxicillin 1 g tds × 21d</li><li>Azithromycin 500 mg od × 17d </li></ul></td><td rowspan="5"><p>Doxycycline 5 mg/kg day 1, then 2.5 mg/kg</p><p>IV Ceftriaxone 80 mg/kg od</p></td><td rowspan="5"><p>Avoid doxycycline</p><p>Amoxicillin 30 mg/kg tds</p><p>IV Ceftriaxone 80 mg/kg od</p></td><td rowspan="5"><p>Avoid doxycycline</p></td></tr><tr><td><p><strong>Central nervous system</strong></p></td><td><ul><li><strong>IV Ceftriaxone 4 g × 21d </strong></li><li><strong>D</strong>oxycycline 200 mg bd × 21d</li></ul></td></tr><tr><td><p><strong>Arthritis </strong></p><p><strong>Acrodermatitis chronica atrophicans</strong></p></td><td><ul><li><strong>Doxycycline 100 mg bd × 28d </strong></li><li><strong>Amoxicillin 1 g tds × 28d </strong></li><li><strong>IV Ceftr</strong>iaxone 2 g × 28d</li></ul></td></tr><tr><td><p><strong>Lyme carditis – stable</strong></p></td><td><ul><li><strong>Doxycycline 100 mg bd × 21d</strong></li><li>IV Ceftriaxone 2 g × 21d</li></ul></td></tr><tr><td><p><strong>Lyme carditis – unstable</strong></p></td><td><ul><li><strong>IV Ceftriaxone 2 g × 21d</strong> </li></ul></td></tr></table><p><strong>Special notes:</strong></p><ul><li>Children: doxycycline allowed from 9y if severe (off-label but NICE-endorsed).</li><li>Azithromycin: reserve if others unsuitable; avoid in carditis.</li><li>Pregnancy: avoid doxycycline/azithromycin → use amoxicillin or ceftriaxone.</li><li>Jarisch–Herxheimer reaction may occur after antibiotics.</li></ul><h2 class="text-xl font-semibold mt-6 mb-3"><strong>II. Relapsing Fevers (LBRF, TBRF, B. miyamotoi)</strong></h2><h3 class="text-lg font-semibold mt-6 mb-3"><strong>Epidemiology</strong></h3><ul><li><strong>Louse-borne RF (LBRF):</strong> <em>B. recurrentis</em>, transmitted by <em>Pediculus humanus corporis</em>.<ul><li>Human-only host.</li><li>Historically epidemic; now Horn of Africa, refugee/homeless settings in Europe.</li></ul></li><li><strong>Tick-borne RF (TBRF):</strong> Many species (<em>B. hermsii, B. duttonii, B. turicatae</em> etc.).<ul><li>Soft ticks (<em>Ornithodoros</em> spp.) → feed rapidly at night, unnoticed.</li><li>Africa, Asia, Americas, southern Europe.</li></ul></li><li><strong><em>Borrelia miyamotoi</em>:</strong> <ul><li><em>Ixodes</em> hard ticks (same as Lyme). </li><li>Found in Europe, Russia, Japan, US. </li><li>Maintained in rodent reservoirs.</li></ul></li></ul><h3 class="text-lg font-semibold mt-6 mb-3"><strong>Clinical Features</strong></h3><ul><li>Incubation 7–12 d. </li><li>Sudden high fever, chills, sweats, headache, myalgia, GI upset. </li><li>Rash sometimes.</li><li><strong>Relapsing fever episodes:</strong> 2–7 d febrile illness alternating with afebrile periods (days–weeks).</li><li>Relapses due to antigenic variation.</li><li><strong>LBRF:</strong><ul><li>Severe, often 1–5 relapses.</li><li>CFR up to 30–70% untreated.</li><li>Complications: hepatosplenomegaly, jaundice, nephritis, myocarditis, neuropathy, meningitis.</li></ul></li><li><strong>TBRF:</strong><ul><li>Milder, more relapses (up to 10–11).</li><li>CFR &lt;10% (higher in pregnancy/children).</li><li>Neuro/myocardial involvement more common than Lyme.</li></ul></li><li><strong><em>B. miyamotoi</em>:</strong> Febrile illness ± relapses (~10%), sometimes neuro/cognitive involvement. Mild leucopenia, ↑transaminases.</li></ul><h3 class="text-lg font-semibold mt-6 mb-3"><strong>Diagnosis</strong></h3><ul><li><strong>Blood films during fever:</strong> Large spirochaetes visible on Giemsa/Field stains. Sensitivity 70% LBRF, lower TBRF.</li><li><strong>Buffy coat, dark-field/phase-contrast</strong> can aid detection.</li><li><strong>PCR</strong>: sensitive, species identification.</li><li><strong>Culture</strong>: experimental, not routine.</li><li><strong>Serology</strong>: limited, cross-reactive, not standardised.</li></ul><h3 class="text-lg font-semibold mt-6 mb-3"><strong>Treatment</strong></h3><table><tr><td><p><strong>Condition</strong></p></td><td><p><strong>Treatment</strong></p></td></tr><tr><td><p><strong>LBRF</strong> <em>B. recurrentis</em></p></td><td><p><strong>Single-dose doxycycline 100 mg</strong> </p><p>(alt. IM procaine penicillin, erythromycin).</p></td></tr><tr><td><p><strong>TBRF</strong> </p></td><td><p><strong>Doxycycline 100 mg bd × 5–10 d</strong> </p><p>(alt erythromycin).</p></td></tr><tr><td><p><strong>CNS involvement</strong></p></td><td><p><strong>IV Ceftriaxone 2 g od × 10–14 d</strong> </p><p>(alt. IV penicillin G 3 MU q4h).</p></td></tr><tr><td><p><strong><em>B. miyamotoi</em></strong></p></td><td><p> Doxycycline 100 mg bd × 10–14 d.</p></td></tr><tr><td><p><strong>Jarisch–Herxheimer reaction</strong></p></td><td><p>Occurs in 30–100% (esp. LBRF). Supportive management essential.</p></td></tr></table><h1 class="text-2xl font-bold mt-8 mb-4"><strong>Exam Pearls</strong></h1><ul><li><strong>EM rash = treat empirically</strong> (do not wait for serology).</li><li><em>B. garinii</em> → neuroborreliosis; <em>B. afzelii</em> → acrodermatitis; <em>B. burgdorferi</em> s.s. → arthritis.</li><li><strong>Jarisch–Herxheimer reaction</strong>: must mention in relapsing fever answers.</li><li>LBRF = human-specific, higher mortality. TBRF = zoonotic, more relapses, lower mortality.</li><li><em>B. miyamotoi</em> transmitted by <em>Ixodes</em> ticks but clinically resembles relapsing fever.</li><li>Post-treatment Lyme symptoms do <strong>not</strong> indicate active infection → prolonged antibiotics not recommended.</li></ul>
</div>